SCHOTT Pharma AG & Co. KGaA (1SXP) — Defensive Interval Ratio
SCHOTT Pharma AG & Co. KGaA (1SXP) has a Defensive Interval Ratio of 149 days as of September 2024. Defensive assets of €178.14 Million (cash €-, short-term investments €3.25 Million, receivables €174.89 Million) cover 149 days of daily cash needs of €1.19 Million/day. Check SCHOTT Pharma AG & Co. KGaA tangible book value ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
SCHOTT Pharma AG & Co. KGaA Defensive Interval Ratio (2020–2024)
This chart shows how SCHOTT Pharma AG & Co. KGaA's Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2024, the ratio stands at 149 days, meaning defensive assets of €178.14 Million can fund 149 days of operations without new revenue. Also explore 1SXP net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for SCHOTT Pharma AG & Co. KGaA (2020–2024)
The table below presents the year-by-year Defensive Interval Ratio for SCHOTT Pharma AG & Co. KGaA from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see SCHOTT Pharma AG & Co. KGaA stock valuation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 149 days | €178.14 Million | €1.19 Million/day | €- | €3.25 Million | ▼ -24 days |
| 2023 | 174 days | €167.02 Million | €962.04K/day | €- | €1.53 Million | ▲ +6 days |
| 2022 | 167 days | €147.92 Million | €884.98K/day | €- | €1.49 Million | ▼ -9 days |
| 2021 | 176 days | €117.62 Million | €669.06K/day | €- | €- | ▲ +3 days |
| 2020 | 173 days | €99.52 Million | €574.95K/day | €- | €- | — |